DOJ Joins Suboxone Whistleblower Cases
The Justice Department filed notice that it plans to intervene in four False Claims Act lawsuits accusing Indivior and Reckitt of improperly marketing the opioid anti-addiction drug Suboxone.
Source: Drug Industry Daily